US Patent Issued to Sun Pharmaceutical Industries on Aug. 11 for "Process for preparing a composition comprising enantiomerically enriched pyrrolo[2,3-dpyrimidines" (New Jersey, Massachusetts, California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,704, issued on Aug. 11, was assigned to Sun Pharmaceutical Industries Inc. (Princeton, N.J.).

"Process for preparing a composition comprising enantiomerically enriched pyrrolo[2,3-dpyrimidines" was invented by Robert S. Lewis (Princeton, N.J.), Mahender Reddy Karla (Princeton, N.J.), Kathryn E. Kavouris (Folsom, Calif.), Yong Dong (Chestnut Hill, Mass.), Adam J. Morgan (Ashland, Mass.) and Cameron J. Cowden (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Improved processes and intermediates for preparing ruxolitinib and deuterated analogs of ruxolitinib of Formula I: wherein, Y1 is hydrogen or deuterium; each Y2 is the same and is h...